Work

Organometallic Anticancer Compounds

Year: 2010

Type: review

Abstract: The quest for alternative drugs to the well-known cisplatin and its derivatives, which are still used in more than 50 % of the treatment regimes for patients suffering from cancer, is highly needed. 1,2 Despite their tremendous success, these

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm100020w

Authors: Gilles Gasser, Ingo Ott, Nils Metzler-Nolte

Institutions: University of Zurich, Ruhr University Bochum, Technische Universität Braunschweig

Language: English

Topic: Metal complexes synthesis and properties

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,500